These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 28922344)
1. Comparison table: drugs for Alzheimer's disease. Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344 [No Abstract] [Full Text] [Related]
2. Drugs for cognitive loss and dementia. Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342 [No Abstract] [Full Text] [Related]
3. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667 [No Abstract] [Full Text] [Related]
4. [Therapy in Alzheimer disease]. Kovács T Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971 [No Abstract] [Full Text] [Related]
5. What is the rationale for new treatment strategies in Alzheimer's disease? Rogawski MA CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294 [TBL] [Abstract][Full Text] [Related]
6. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969 [No Abstract] [Full Text] [Related]
7. Medications for Alzheimer's disease. Benefits of currently approved drugs are limited, but research continues. Harv Ment Health Lett; 2011 Apr; 27(10):4-5. PubMed ID: 21786469 [No Abstract] [Full Text] [Related]
8. [Practical clinical use of therapeutic agents for Alzheimer's disease]. Arai T Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):494-8. PubMed ID: 18079601 [No Abstract] [Full Text] [Related]
9. Memantine: a new approach to Alzheimer's disease. Keltner NL; Williams B Perspect Psychiatr Care; 2004; 40(3):123-4. PubMed ID: 15515294 [No Abstract] [Full Text] [Related]
10. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
11. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. Rockwood K; Fay S; Gorman M Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273 [TBL] [Abstract][Full Text] [Related]
12. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review]. Strnad J; Bahro M Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539 [No Abstract] [Full Text] [Related]
13. [Symptomatic therapy of Alzheimer dementia]. Förstl H Wien Med Wochenschr; 2002; 152(3-4):77-80. PubMed ID: 11925776 [TBL] [Abstract][Full Text] [Related]
14. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
15. Drugs for Alzheimer's disease. Cranwell-Bruce LA Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985 [No Abstract] [Full Text] [Related]
16. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314 [TBL] [Abstract][Full Text] [Related]
17. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
18. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related]
19. [Cholesterol inhibitor and memantine in symptomatic dementia therapy]. Rodda J; Carter J Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240 [No Abstract] [Full Text] [Related]
20. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches. Hake AM Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]